73
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity

&
Pages 6009-6018 | Published online: 05 Oct 2018

References

  • DeSantisCELinCCMariottoABCancer treatment and survivorship statistics, 2014CA Cancer J Clin201464425227124890451
  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
  • ZarogoulidisPPatakaATerziEIntensive care unit and lung cancer: when should we intubate?J Thorac Dis20135Suppl 4S407S41224102014
  • KrennLKoppBBufadienolides from animal and plant sourcesPhytochemistry19984811299621450
  • QiFLiAInagakiYAntitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans CantorInt Immunopharmacol201111334234921185919
  • LuCXNanKJLeiYAgents from amphibians with anticancer propertiesAnticancer Drugs2008191093193918827558
  • CuiXInagakiYXuHAnti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cellsBiol Pharm Bull201033101728173220930383
  • KangXHZhangJHZhangQQDegradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 CellsCell Physiol Biochem20174152067207628419994
  • MiaoQBiLLLiXAnticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagyInt J Mol Sci20131411370138223344047
  • XieCMChanWYYuSZhaoJChengCHBufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activationFree Radic Biol Med20115171365137521763418
  • AmanoYChoYMatsunawaMKomiyamaKMakishimaMIncreased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cellsJ Steroid Biochem Mol Biol20091143–514415119429444
  • LiDQuXHouKPI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cellsAnticancer Drugs2009201596419343001
  • ShenSZhangYWangZLiuRGongXBufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stressInt J Biol Sci201410221222424550689
  • TsaiSCYangJSPengSFBufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cellsInt J Oncol20124141431144222858649
  • ChenYYLuHFHsuSCBufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathwaysEnviron Toxicol2015301748223949904
  • HuQLiangBSunYPreparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancerInt J Nanomedicine2014914035404125187707
  • KimSSRaitARubabFThe clinical potential of targeted nanomedicine: delivering to cancer stem-like cellsMol Ther201422227829124113515
  • LiMZhangWWangBGaoYSongZZhengQCLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaInt J Nanomedicine2016115645566927920520
  • ZhaoRMatherlyLHGoldmanIDMembrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesExpert Rev Mol Med200911e419173758
  • O’ShannessyDJYuGSmaleRFolate receptor alpha expression in lung cancer: diagnostic and prognostic significanceOncotarget20123441442522547449
  • AssarafYGLeamonCPReddyJAThe folate receptor as a rational therapeutic target for personalized cancer treatmentDrug Resist Updat2014174–6899525457975
  • SiafakaPBetsiouMTsolouASynthesis of folate-pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cellsJ Mater Sci Mater Med2015261227526543021
  • DanielsTRBernabeuERodríguezJAThe transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochim Biophys Acta20121820329131721851850
  • KoshkaryevAPiroyanATorchilinVPIncreased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomesCancer Biol Ther2012131506022336588
  • SapraPAllenTMImproved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopesClin Cancer Res20041072530253715073133
  • HareJIMoaseEHAllenTMTargeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancerJ Drug Target2013211879623039213
  • SriramanSKSalzanoGSarisozenCTorchilinVAnti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acidEur J Pharm Biopharm2016105404927264717
  • GaoJQLvQLiLMGlioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomesBiomaterials201334225628563923628475
  • KolhatkarRLoteAKhambatiHActive tumor targeting of nanomaterials using folic acid, transferrin and integrin receptorsCurr Drug Discov Technol20118319720621696360
  • YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
  • SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
  • PaulosCMReddyJALeamonCPTurkMJLowPSLigand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug deliveryMol Pharmacol20046661406141415371560